Phathom Pharmaceuticals
PHAT
PHAT
114 hedge funds and large institutions have $588M invested in Phathom Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 117 → 114 (-3)
18% less call options, than puts
Call options by funds: $811K | Put options by funds: $991K
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
Holders
114
Holding in Top 10
9
Calls
$811K
Puts
$991K
Top Buyers
| 1 | +$39.3M | |
| 2 | +$17.5M | |
| 3 | +$4.53M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$4.3M |
| 5 |
6CM
683 Capital Management
New York
|
+$3.93M |
Top Sellers
| 1 | -$45.7M | |
| 2 | -$6.08M | |
| 3 | -$5.63M | |
| 4 |
NM
Newtyn Management
New York
|
-$5.12M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$4.65M |